J06BB21 bezlotoxumab
ATC group of level 5 – chemical substance · in plain English: antibodies (immunoglobulins)
This site has the patient leaflet or the SPC of 2 medicines in this group.
- 2 no longer supplied or not available
Active substance: Bezlotoxumab – all medicines with this substance, also in combinations.
Place in the ATC classification
- J Antiinfectives for systemic use 1,393 medicines
- J06 Immune sera and immunoglobulins 47 medicines
- J06B Immunoglobulins 47 medicines
- J06BB Specific immunoglobulins 18 medicines
- J06BB21 bezlotoxumab 2 medicines
- J06BB Specific immunoglobulins 18 medicines
- J06B Immunoglobulins 47 medicines
- J06 Immune sera and immunoglobulins 47 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Zinplava SPC no longer supplied | – |
| Zinplava concentrate for solution for infusion 25 mg / ml SPC no longer supplied | – |
Other groups of the same level
- J06BB01 anti-D (rh) immunoglobulin 3 medicines
- J06BB02 tetanus immunoglobulin 1 medicine
- J06BB03 varicella/zoster immunoglobulin 1 medicine
- J06BB04 hepatitis B immunoglobulin 5 medicines
- J06BB05 rabies immunoglobulin 1 medicine
- J06BB09 cytomegalovirus immunoglobulin 1 medicine
- J06BB16 palivizumab 1 medicine
- J06BB22 obiltoxaximab 2 medicines
Other names of the ATC group
- German: J06BB21 Bezlotoxumab
- German: J06BB21 Bezlotoxumab
- Polish: J06BB21 BEZLOTOXUMAB
- Turkish: J06BB21 bezlotoksumab
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group J06BB21
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.